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outh with substance use disorders often also face mental health challenges. Two recent studies analyzed
two different treatment approaches for co-occurring substance use and mental health disorders: (1) a
standardized therapy approach and (2) 12-step support groups, as modalities for effectively treating and
continuing positive outcomes for young people with co-occurring mental health and substance use issues. The findings from these studies are summarized below.

APPROACH 1: COGNITIVE BEHAVIORAL THERAPY
AND MOTIVATIONAL ENHANCEMENT THERAPY

Cornelius and colleagues (2011) conducted a two-year follow up
study on participants in two studies they had conducted previously to
determine the long-term effects of using Cognitive Behavioral Therapy
(CBT) and Motivational Enhancement Therapy (MET) together to
address co-morbidity in adolescents. In one study, participants had
received CBT/ MET to treat their co-morbid conditions. In the other
study, participants received treatment as usual (TAU); this second study
provided a naturalistic control group for the long-term follow up.
The authors described CBT as a therapy approach based on social
learning models that focuses on developing an understanding of the
triggers and consequences of drug use. They also stated that their
implementation of CBT teaches coping skills to manage craving and
other high-risk situations for use. The authors defined MET as an
intervention used to increase an individual’s engagement in therapy
using motivation to make beneficial changes around substance use and
high-risk behaviors. This intervention specifically was chosen as a way
to encourage treatment adherence in young people because, according
to the study authors, young people with substance use disorders have
historically possessed low rates of treatment engagement.
At baseline, participants were between 15-20 years old and were
diagnosed with both major depressive disorder (MDD) and an alcohol
12
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CBT/ MET can reduce both
mental health symptoms
and substance use in young
people with co-occurring
disorders two years after
treatment. Young people
who had high rates of
participation in a 12-step
program had higher levels of
abstinence from alcohol and
drugs years later.
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use disorder (AUD). Participants in the first study then
received the intervention treatment of CBT/ MET, and
those in study two received TAU. Those who received
CBT/ MET received the treatment nine times over
twelve weeks. Additionally, half of the intervention
group also received Fluoxetine, an SSRI antidepressant
medication. However, immediately after treatment
there were no differences in mental health or substance
use outcomes between the group that received the
SSRI and the group that did not, so the two groups were
combined in the long-term follow up. Other differences
between those who received medication and those
who did not were compared in a separate analysis.
Out of the 118 participants from the two initial
studies, 75 completed the two-year follow up assessment: 48 who had received CBT/ MET and 27 from the
TAU study. Differences in substance use and depressive
symptoms between the two groups at baseline and two
years after treatment were assessed using repeated
measures analysis of variance (ANOVA).
Before the treatment phase, those in the CBT/ MET
group demonstrated higher depressive symptomatology than those in TAU. There were no differences
between the two groups in terms of AUD. After two
years, there were no differences in outcomes between
those in the CBT/ MET group who received medication and those who did not. Long term follow up did
indicate that both the intervention group and TAU
group demonstrated decreased diagnostic criteria in
both depressive symptoms and alcohol use between
the two time points. However, those in the CBT/ MET
group demonstrated significantly more improvements
than those participants in the TAU group. More specifically, analyses found significantly decreased depressive
symptoms on three assessments including the number
of DSM criteria for MDD (f = 14.6, p = 0.000), the Beck
Depression Inventory (f = 12.4, p = 0.001) and the
Hamilton Depression Rating scale (f = 16.6, p = 0.000).
A significantly greater improvement in the DSM criteria
for alcohol use disorder was also found in the CBT/ MET
group (f = 14.2, p = 0.000).
These results demonstrate that, in combination, CBT
and MET may be an effective treatment for adolescents
diagnosed with both MDD and AUD. The effects of this
approach lasted two years past treatment. The SSRI
Fluoxetine did not appear effective when combined
with CBT/ MET in either the short or long term for this
particular group. However, the small sample size used
to assess long term effectiveness is a limitation to this
study and replication of its findings are warranted.

long-term effects of participating in a 12-step program
on post-treatment substance use abstinence for youth
with and without mental health challenges.
Participants for this seven-year study (N=419)
were recruited from four Kaiser Permanente Chemical
Dependency Recovery Programs in California, and were
aged 13-18 at baseline. This sample was 34% female,
and race/ ethnic distribution was as follows: 50% of
participants reported as Caucasian, 21% Hispanic, 14%
African American, 8% Native American, and 6% Asian/
Pacific Islander.
Psychiatric diagnoses were taken from Kaiser
Permanente’s inpatient and outpatient databases.
Adolescents with co-occurring disorders were those
who received at least one psychiatric diagnosis on
the International Classification of Diseases (ICD)-9 in
the two years prior to the study through six months
after entering substance abuse treatment. Severity of
symptoms was measured at intake by internalizing and
externalizing scales on the Youth Self-Report questionnaire (YSR). Follow up evaluations were conducted by
phone at one, three, five, and seven years after intake.
To measure 12-step group participation, the Alcoholics Anonymous (AA) Affiliation scale was modified to include Narcotics Anonymous (NA), Cocaine
Anonymous (CA) and other 12-step groups. Meeting
attendance was measured by the number of meetings
attended in the six months prior to the assessment;
activity involvement within the program (e.g., considering oneself a member, having a sponsor, having
sponsored anyone, calling other members for help,
etc.) was measured by adding up the total number of
activities selected (scores ranging from 0 to a maximum
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of 3+). Substance use was measured by assessing thirtyday abstinence from alcohol and drug use measured at
each time interval.
Differences between adolescents with co-occurring
disorders and those with only substance use issues
were compared. At baseline, when compared to those
who presented with only a substance use disorder,
adolescents with co-occurring issues had higher levels
of substance use, reported more abuse/ dependence
symptoms and had higher YSR internalizing and externalizing scores. There were no differences in substance
use treatment retention or length of stay between the
two groups at any time intervals. However, 12-step
meetings were more highly attended in years one and
three by young people with co-occurring diagnoses
than those who were just managing a substance use
disorder (33% vs. 19%, p = .0032; and 16% vs. 7%, p =
0.0106). Those with co-morbid conditions also reported
being abstinent more often than those with SUD only.
Analyses were conducted to examine the relationship between post-treatment participation in 12-step
groups and substance use outcomes for young people
with both co-occurring and substance abuse-only
diagnoses. Adolescents with and without co-occurring
disorders who attended at least ten 12-step meetings in
the prior six months of each measurement interval were
more than three and five times as likely to be abstinent
from alcohol at follow-ups as those who attended fewer
or no meetings (OR = 3.02, P = .0049; and OR = 5.29, P
=.0063, respectively). Adolescents in both groups who
had high meeting attendance were also 5 times more
likely to be abstinent from drugs. Similarly, those with
and without co-occurring disorders who were more
actively involved in their 12-step programs were more
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than twice and eight times as likely to be abstinent from
alcohol over time as those with less involvement (OR =
2.55, P = .0322; and OR = 8.17, P < .0001, respectively).
Results from this study show that 12-step programs
may help some young people with psychiatric and substance use issues maintain abstinence from substance
use over the long-term.

CONCLUSION
These two recent studies demonstrate promising
initial results regarding the long-term effectiveness of
various non-medicine based treatment approaches
for supporting adolescents and young adults with cooccurring disorders. The first study showed that CBT/
MET can reduce both mental health symptoms and substance use in young people with co-occurring disorders
two years after treatment. The second study found that
those young people with co-occurring disorders who
had high rates of participation in a 12-step program
had higher levels of abstinence from alcohol and drugs
years later. However, more research needs to be done
to replicate these findings and to better understand the
best ways to treat young people who face both mental
health and substance use challenges.
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